A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Neurovalens, a Belfast-based startup that's been developing technology to deliver noninvasive electrical stimulation of the brain and nervous system for almost a decade, has had its second head-mounted treatment device cleared by the FDA.